Incidence of long-term cardiotoxicity and evolution of the systolic function in patients with breast cancer treated with anthracyclines.

CONCLUSIONS: The incidence of long-term cardiotoxicity in patients treated with low-cumulative dose of anthracyclines is high, 16.5% at 4.5 years. This was observed in almost all cases after the first year of follow-up. Therefore, long-term monitoring may be advisable.
PMID: 32329038 [PubMed - as supplied by publisher]

Source: Cardiology Journal - April 23, 2020 Category: Cardiology Authors: Mata Caballero R, Serrano Antolín JM, Jimenez Hernandez RM, Talavera Calle P, Curcio Ruigomez A, Del Castillo Arrojo S, Graupner Abad C, Cristóbal Varela C, Alonso Martín JJ Tags: Cardiol J Source Type: research